INOVIQ Ltd (ASX:IIQ)
Australia · Delayed Price · Currency is AUD 0.1750
+0.0050 (2.94%)
Sep 17, 2026, 1:27 PM AEST
INOVIQ Market Cap
INOVIQ has a market cap or net worth of 23.93 million as of September 16, 2026. Its market cap has decreased by -44.32% in one year.
Market Cap
23.93M
Enterprise Value
14.87M
Revenue
2.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.18
ChartMarket Cap Chart
Since June 20, 2016, INOVIQ's market cap has increased from 13.25M to 23.93M, an increase of 80.65%. That is a compound annual growth rate of 5.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 23.93M | -56.13% |
| Dec 31, 2025 | 54.55M | -5.02% |
| Dec 31, 2024 | 57.44M | -6.14% |
| Dec 29, 2023 | 61.19M | 3.91% |
| Dec 30, 2022 | 58.89M | -46.44% |
| Dec 31, 2021 | 109.96M | 102.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 505.18M |
| Healius | 308.62M |
| Monash IVF Group | 305.86M |
| Cryosite | 57.60M |
| Microba Life Sciences | 37.82M |
| Rhythm Biosciences | 29.02M |
| BCAL Diagnostics | 26.18M |
| Genetic Signatures | 18.40M |